Anifrolumab for refractory lupus erythematosus panniculitis in systemic lupus erythematosus

Journal Article Corrected proof Anifrolumab for refractory lupus erythematosus panniculitis in systemic lupus erythematosus Get access Keisuke Maeshima, Keisuke Maeshima Department of Rheumatology, Nishida Hospital, Oita, Japan Correspondence to: Keisuke Maeshima, Department of Rheumatology, Nishida Hospital, Tsuruoka-Nishi-Machi 2-266, Saiki, Oita 876-0047, Japan. E-mail: maeshima@oita-u.ac.jp https://orcid.org/0000-0002-9251-5997 Search for other works by this author on: Oxford Academic PubMed Google Scholar Tasuku Abe, Tasuku Abe Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Oita, Japan Search for other works by this author on: Oxford Academic PubMed Google Scholar Chiharu Imada, Chiharu Imada Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Oita, Japan Search for other works by this author on: Oxford Academic PubMed Google Scholar Takashi Ozaki, Takashi Ozaki Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Oita, Japan Search for other works by this author on: Oxford Academic PubMed Google Scholar Hirotaka Shibata Hirotaka Shibata Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Oita, Japan Search for other works by this author on: Oxford Academic PubMed Google Scholar Rheumatology, kead553, https://doi.org/10.1093/rheumatology/kead553 Published: 11 October 2023 Article history Accepted: 06 October 2023 Published: 11 October 2023 Corrected and typeset: 26 October 2023